We found for
Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds

Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?

Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty

Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
